Ketorolac

Generic Name
Ketorolac
Brand Names
Acular, Acuvail, Omidria, Readysharp Anesthetics Plus Ketorolac, Sprix, Toradol, Toronova Suik
Drug Type
Small Molecule
Chemical Formula
C15H13NO3
CAS Number
74103-06-3
Unique Ingredient Identifier
YZI5105V0L
Background

Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.
...

Indication

Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties. It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids. Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid...

Associated Conditions
Acute Migraine, Eye Pain, Inflammation, Macular Edema, Cystoid, Ocular Itching, Pericarditis Acute, Pseudophakic Cystoid Macular Oedema, Severe Acute Pain, Acute, moderate Pain, Chronic aphakic cystoid macular edema, Intraoperative miosis, Postoperative ocular pain
Associated Therapies
-

Intravenous Fluids in Pediatric Migraine

First Posted Date
2023-12-26
Last Posted Date
2023-12-26
Lead Sponsor
Dayton Children's Hospital
Target Recruit Count
134
Registration Number
NCT06182098
Locations
🇺🇸

Dayton Children's Hosptial, Dayton, Ohio, United States

Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain

First Posted Date
2023-12-07
Last Posted Date
2024-06-24
Lead Sponsor
University of Calgary
Target Recruit Count
495
Registration Number
NCT06160778
Locations
🇨🇦

Alberta Children's Hospital Emergency Department, Calgary, Alberta, Canada

The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA

First Posted Date
2023-11-01
Last Posted Date
2024-05-02
Lead Sponsor
Damascus University
Target Recruit Count
80
Registration Number
NCT06112548
Locations
🇸🇾

Damascus university, Damascus, Syrian Arab Republic

Intranasal Ketorolac Trial

First Posted Date
2023-10-16
Last Posted Date
2024-07-24
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
120
Registration Number
NCT06083571
Locations
🇺🇸

Washington University in St. Louis, Saint Louis, Missouri, United States

Modified Thoracoabdominal Nerves Block Through Perichondrial Approach: a New Strategy With a Wide Range of Utilization in Laparoscopic Gynecological Surgeries.

First Posted Date
2023-09-15
Last Posted Date
2023-09-15
Lead Sponsor
Alexandria University
Target Recruit Count
60
Registration Number
NCT06039423
Locations
🇪🇬

Alexandria University Faculty of Medicin, Alexandria, Egypt

Pain Treatment With Combinations of NSAIDs

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2023-08-16
Last Posted Date
2024-01-25
Lead Sponsor
Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty
Target Recruit Count
105
Registration Number
NCT05994287
Locations
🇷🇺

Federal Center for Traumatology, Orthopedics and Endoprosthetics, Cheboksary, Chuvashia, Russian Federation

NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2023-08-15
Last Posted Date
2024-11-26
Lead Sponsor
Mayo Clinic
Target Recruit Count
240
Registration Number
NCT05992883
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement

First Posted Date
2023-05-25
Last Posted Date
2024-07-31
Lead Sponsor
Arkansas Children's Hospital Research Institute
Target Recruit Count
18
Registration Number
NCT05875571
Locations
🇺🇸

Arkansas Childrens Hospital, Little Rock, Arkansas, United States

NSAID Use After Robotic Partial Nephrectomy

First Posted Date
2023-05-03
Last Posted Date
2024-10-08
Lead Sponsor
University of Miami
Target Recruit Count
110
Registration Number
NCT05842044
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2023-03-20
Last Posted Date
2024-05-20
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
86
Registration Number
NCT05776953
Locations
🇺🇸

Hackensack Univarsity medical Center, Hackensack, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath